Circadian Oscillations of Minimal Erythema Dose (MED) are Also Influenced by Diet in Patients with Psoriasis: A Chronomedical Study
- PMID: 37573289
- PMCID: PMC10539244
- DOI: 10.1007/s13555-023-00987-z
Circadian Oscillations of Minimal Erythema Dose (MED) are Also Influenced by Diet in Patients with Psoriasis: A Chronomedical Study
Abstract
Introduction: Minimal erythema dose (MED) remains a parameter of paramount importance to orient narrow-band (NB)-UVB phototherapy in psoriatic (PsO) patients. Recently, circadian rhythm and diet were recognized as potential MED modulators, but their mutual interaction remains understudied. Thus, we aimed to evaluate the potential diet modulation of MED circadian oscillations.
Methods: In the first phase, a cohort study was performed comparing potential MED oscillations (morning, afternoon, and evening) among omnivorous psoriatic patients before and after a phototherapy cycle and omnivorous healthy controls. The two groups were age-, gender-, skin-type-, MED-, and diet-matched. Then, in the second phase, another cohort study was carried out comparing MED oscillations 24 h after the last phototherapeutic session only in psoriatic patients cleared with NB-UVB and undergoing different diets (vegan, vegetarian, paleo , ketogenic, intermittent circadian fasting, and omnivore). Patients with different diets were age-, gender-, and skin-type matched.
Results: In the first phase, we enrolled only omnivores, specifically 54 PsO patients and 54 healthy individuals. Their MED before and after NB-UVB therapy changed significantly among the three different time-points (morning, afternoon, and evening) (p < 0.001). The time effect was statistically significant in both groups before and after phototherapy. In the second phase, we enrolled 144 PsO patients (vegan, vegetarian, paleo, ketogenic, intermittent circadian fasting, and omnivore). MED circadian oscillations preserved a significant difference also after clearance and were influenced by diet type and time of day (p < 0.001). In particular, vegans displayed the lowest MED values, whilst Ramadan fasting showed the highest values in morning, afternoon, and evening.
Conclusions: Diet, like other ongoing therapies, should be reported in the medical records of patients with psoriasis undergoing NB-UVB and patients with lower MEDs should be preferentially treated in the morning when the MED is higher.
Keywords: Circadian rhythm; Diet; Intermittent circadian fasting; Ketogenic diet; Minimal erythema dose (MED); Narrow-band-UVB (NB-UVB); Paleolithic diet; Phototherapy; Psoriasis; Vegan diet; Vegetarian diet.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Diet-Related Phototoxic Reactions in Psoriatic Patients Undergoing Phototherapy: Results from a Multicenter Prospective Study.Nutrients. 2021 Aug 25;13(9):2934. doi: 10.3390/nu13092934. Nutrients. 2021. PMID: 34578812 Free PMC article.
-
Photoadaptation to ultraviolet B TL01 in psoriatic patients.J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1750-1754. doi: 10.1111/jdv.16209. Epub 2020 Apr 27. J Eur Acad Dermatol Venereol. 2020. PMID: 31967696
-
Could colorimetric method replace the individual minimal erythemal dose (MED) measurements in determining the initial dose of narrow-band UVB treatment for psoriasis patients with skin phototype III-V?J Eur Acad Dermatol Venereol. 2013 Apr;27(4):494-8. doi: 10.1111/j.1468-3083.2012.04471.x. Epub 2012 Feb 20. J Eur Acad Dermatol Venereol. 2013. PMID: 22340091
-
Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.J Eur Acad Dermatol Venereol. 2012 May;26 Suppl 3:22-31. doi: 10.1111/j.1468-3083.2012.04520.x. J Eur Acad Dermatol Venereol. 2012. PMID: 22512677 Review.
-
[Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].Ann Dermatol Venereol. 2010 Jan;137(1):21-31. doi: 10.1016/j.annder.2009.12.004. Epub 2009 Dec 29. Ann Dermatol Venereol. 2010. PMID: 20110064 Review. French.
Cited by
-
Sociodemographic and Environmental Determinants of Regional Prevalence of Psoriasis in Germany: A Spatiotemporal Study of Ambulatory Claims Data.Acta Derm Venereol. 2024 Feb 7;104:adv12430. doi: 10.2340/actadv.v104.12430. Acta Derm Venereol. 2024. PMID: 38323497 Free PMC article.
-
The role of bilirubin as a biomarker of rheumatic diseases: a systematic review and meta-analysis.Front Immunol. 2024 Jun 14;15:1369284. doi: 10.3389/fimmu.2024.1369284. eCollection 2024. Front Immunol. 2024. PMID: 38947324 Free PMC article.
-
Assessing causal relationships between gut microbiota and psoriasis: evidence from two sample Mendelian randomization analysis.Sci Rep. 2024 Apr 17;14(1):8831. doi: 10.1038/s41598-024-59603-5. Sci Rep. 2024. PMID: 38632320 Free PMC article.
-
A systematic review and meta-analysis of the kynurenine pathway of tryptophan metabolism in rheumatic diseases.Front Immunol. 2023 Oct 23;14:1257159. doi: 10.3389/fimmu.2023.1257159. eCollection 2023. Front Immunol. 2023. PMID: 37936702 Free PMC article.
-
Anti-Interleukin 17A Biologic Therapy Attempts on Livedoid Vasculopathy: A Report of Case Series.Clin Cosmet Investig Dermatol. 2024 May 9;17:1043-1048. doi: 10.2147/CCID.S455903. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 38742169 Free PMC article.
References
-
- Damiani G, Franchi C, Pigatto P, Altomare A, Pacifico A, Petrou S, et al. Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new direct-acting antiviral agents. World J Hepatol. 2018;10(2):329–336. doi: 10.4254/wjh.v10.i2.329. - DOI - PMC - PubMed
-
- Damiani G, Bragazzi NL, Garbarino S, Chattu VK, Shapiro CM, Pacifico A, et al. Psoriatic and psoriatic arthritis patients with and without jet-lag: does it matter for disease severity scores? Insights and implications from a pilot, prospective study. Chronobiol Int. 2019;36(12):1733–1740. doi: 10.1080/07420528.2019.1678629. - DOI - PMC - PubMed